81 cancers of the rectosigmoid junction. Colonic or rectal neoplasms?.
DOI:
https://doi.org/10.20344/amp.3146Abstract
With the aim of a better understanding of the cancer of the rectosigmoid junction the authors studied a series of 245 patients treated in Surgery Department 4 with the following distribution according to the localization: 113 in the sigmoid, 81 in the rectosigmoid junction and 51 in the superior rectum. The percentage of cases operated for intestinal obstruction in the rectosigmoid junction (37.0%) was higher than those in the superior rectum (7.8%) (p = 0.001) and the resectability rate of tumours located in the rectosigmoid junction (44.4%) was lower than that of those located in the sigmoid (68.1%) (p = 0.004). In the patients submitted to surgical resection the greater percentage of tumours in stage A and B (58.3%) and with venous invasion (34.4%) was observed in the rectosigmoid junction. Nevertheless, the differences according to the site and shape of the tumour, degree of differentiation, stage and venous invasion were not statistically significant. The 5-year survival rate in 101 cases submitted to resection was higher in patients with tumours in the superior rectum (75.9%) than in patients with carcinomas located in the rectosigmoid junction and in the sigmoid (51.5% and 36.8%, respectively). In summary, this study supported those who consider the rectosigmoid junction cancers as a specific group, based on the particular association of the high frequency of intestinal obstruction and the low resectability rate, apparently related with a special anatomic localization, in a curved segment of the large bowel and suggests that these carcinomas do not constitute, in fact, a colo-rectal independent histopathologic entity.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
